Gateway and journey of patients with cardiac amyloidosis-Reference-Cited by-同舟云学术

Gateway and journey of patients with cardiac amyloidosis

Published:2020-06-26 Issue:5 Volume:7 Page:2418-2430
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Dang Daniel¹²,Fournier Pauline¹²,Cariou Eve¹²,Huart Antoine³,Ribes David³,Cintas Pascal⁴,Roussel Murielle⁵,Colombat Magali⁶,Lavie‐Badie Yoan¹²⁷,Carrié Didier¹²⁸,Galinier Michel¹²⁸,Lairez Olivier¹²⁷⁸

Affiliation:

1. Department of Cardiology Rangueil University Hospital Toulouse France

2. Cardiac Imaging Center Toulouse University Hospital Toulouse France

3. Department of Nephrology and Referral Center for Rare Diseases Rangueil University Hospital Toulouse France

4. Department of Neurology Purpan University Hospital Toulouse France

5. Department of Hematology IUC Oncopole Toulouse France

6. Department of Pathology IUC Oncopole Toulouse France

7. Department of Nuclear Medicine Toulouse University Hospital Toulouse France

8. Medical School Toulouse III Paul Sabatier University Toulouse France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12793

Reference41 articles.

1. Clinical Significance of Histopathologic Patterns of Cardiac Amyloidosis

2. Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

3. Epidemiology of Cardiac Amyloidosis–Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States

4. Updates in Cardiac Amyloidosis: A Review

5. Systemic Amyloidosis in England: an epidemiological study

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptoms of Hereditary Transthyretin Amyloidosis: The Patient and Physician Perspective;Neurology and Therapy;2024-09-06

2. Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years;Heart and Vessels;2024-05-06

3. Best Practices in Nuclear Imaging for the Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in KSA: The Eagle Eyes of Local Experts;Diagnostics;2024-01-18

4. Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network;Clinical Medicine;2024-01

5. The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement;2023-11-14